Keywords: دوزوروبیسین لیپوزوم PEGylated; Breast cancer; Multidrug resistance; Pegylated liposomal doxorubicin; P-glycoprotein; Genetically engineered mouse model;
مقالات ISI دوزوروبیسین لیپوزوم PEGylated (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: دوزوروبیسین لیپوزوم PEGylated; Mononuclear phagocyte system; Tumor-associated macrophages; PEGylated liposomal doxorubicin; Preclinical cancer models; Nanoparticles; AUC; area under the curve; CMA; carrier-mediated agent; EPR; enhanced permeation and retention; GEMM; genetically engine
Keywords: دوزوروبیسین لیپوزوم PEGylated; A/G; albumin/globulin ratio; ALT; alanine transaminase; ALP; alkaline phosphatase; AST; aspartate transaminase; BSA; bovine serum albumin; BUN; blood urea nitrogen; CHOL; cholesterol; CK; cytokeratin; Cre; creatinine; DiI; 1,1â²-dioctadecyl-3,3,3â²3'-
Keywords: دوزوروبیسین لیپوزوم PEGylated; %ID/g; percent injected dose per gram; 125I-FIAU; 125I-labeled fialuridine; 18F-FDG; 18F-labeled fluorodeoxyglucose; 18F-FLT; 18F-labeled fluorothymidine; 18F-FMT; 18F-labeled D-fluoromethyl tyrosine; ADC; apparent diffusion coefficient; BLI; bioluminesce
Keywords: دوزوروبیسین لیپوزوم PEGylated; 18F-FAZA; 18F-labeled fluoroazomycin arabinoside; 18F-FDG; 18F-labeled fluorodeoxyglucose; 18F-FLT; 18F-labeled fluorothymidine; 18F-HX4; 18F-labeled flortanidazole; 18F-MISO; 18F-labeled fluoromisonidazole; 62Cu-ATSM; 62Cu-labeled diacetyl-bis(N-methylth
Keywords: دوزوروبیسین لیپوزوم PEGylated; CED; convection-enhanced delivery; BBB; blood-brain barrier; ACNU; nimustine hydrochloride; BCNU; carmustine; PLD; PEGylated liposomal doxorubicin; PBS; phosphate buffered saline; DAPI; 4â²,6-diamidino-2-phenylindole; NeuN; neuronal nuclear antigen; Br
Keywords: دوزوروبیسین لیپوزوم PEGylated; Pegylated liposomal doxorubicin; MUGA; Echocardiogram; Cardiotoxicity; Cardiac toxicity; Routine surveillance;
Geriatric assessment and biomarkers in patients with metastatic breast cancer receiving first-line mono-chemotherapy: Results from the randomized phase III PELICAN trial
Keywords: دوزوروبیسین لیپوزوم PEGylated; Geriatric assessment; Biomarker; Metastatic breast cancer; Prognostic factor; Pegylated liposomal doxorubicin; Anthracycline; Capecitabine; Elderly;
A phase I trial of intraperitoneal GEN-1, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer, administered with pegylated liposomal doxorubicin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal
Keywords: دوزوروبیسین لیپوزوم PEGylated; GEN-1; IL-12 plasmid; Pegylated liposomal doxorubicin; Primary peritoneal cancer;
Cutaneous T-cell lymphomas: Focusing on novel agents in relapsed and refractory disease
Keywords: دوزوروبیسین لیپوزوم PEGylated; ARGX-110; Brentuximab vedotin; Bortezomib; Copanlisib; cutaneous T-cell lymphoma; Forodesine; Gemcitabine; HDAC inhibitors; Ipilimumab; IPH4102; Mogamulizumab; Nivolumab; NM-IL-12; Panobinostat; Pegylated liposomal doxorubicin; Pentostatin; Pralatrexate;
Original ResearchENGOT-ov-6/TRINOVA-2: Randomised, double-blind, phase 3 study of pegylated liposomal doxorubicin plus trebananib or placebo in women with recurrent partially platinum-sensitive or resistant ovarian cancer
Keywords: دوزوروبیسین لیپوزوم PEGylated; ENGOT-ov-6/TRINOVA-2; Trebananib; Pegylated liposomal doxorubicin; Progression-free survival; Objective response rate; Duration of response;
Phase 1b safety study of farletuzumab, carboplatin and pegylated liposomal doxorubicin in patients with platinum-sensitive epithelial ovarian cancer
Keywords: دوزوروبیسین لیپوزوم PEGylated; Ovarian cancer; Platinum-sensitive relapse; Pegylated liposomal doxorubicin; Farletuzumab; Monoclonal antibody therapy;
Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, Potentiates the Activity of Standard of Care Therapeutics in Ovarian Cancer Models
Keywords: دوزوروبیسین لیپوزوم PEGylated; ADC; antibody-drug conjugate; CI; combination index; CR; complete response; EOC; epithelial ovarian cancer; FRα; folate receptor alpha; PLD; pegylated liposomal doxorubicin;
Selective cardiac surveillance in patients with gynecologic cancer undergoing treatment with pegylated liposomal doxorubicin (PLD)
Keywords: دوزوروبیسین لیپوزوم PEGylated; Pegylated liposomal doxorubicin; Gynecologic malignancy; Cardiotoxicity; Echocardiogram; Surveillance
Pegylated Liposomal Doxorubicin Replacing Conventional Doxorubicin in Standard R-CHOP Chemotherapy for Elderly Patients With Diffuse Large B-Cell Lymphoma: An Open Label, Single Arm, Phase II Trial
Keywords: دوزوروبیسین لیپوزوم PEGylated; Anthracycline; Cardiac toxicity; Diffuse large B-cell lymphoma; Elderly patients; Pegylated liposomal doxorubicin
Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in very platinum-sensitive ovarian cancer patients: Results from a subset analysis of the CALYPSO phase III trial
Keywords: دوزوروبیسین لیپوزوم PEGylated; Pegylated liposomal doxorubicin; Carboplatin; Paclitaxel; Very platinum-sensitive; Ovarian cancer; CALYPSO;
Prevention of palmar-plantar erythrodysesthesia with an antiperspirant in breast cancer patients treated with pegylated liposomal doxorubicin (SAKK 92/08)
Keywords: دوزوروبیسین لیپوزوم PEGylated; Antiperspirant; Breast cancer; Hand-foot syndrome; Palmar-plantar erythrodysesthesia; Pegylated liposomal doxorubicin; Prevention;
The immunomodulatory effects of pegylated liposomal doxorubicin are amplified in BRCA1 − deficient ovarian tumors and can be exploited to improve treatment response in a mouse model
Keywords: دوزوروبیسین لیپوزوم PEGylated; BRCA; Ovarian cancer; Pegylated Liposomal Doxorubicin; Immunomodulation; Host immunity; T cells
Chemotherapy-induced hand-foot syndrome and nail changes: A review of clinical presentation, etiology, pathogenesis, and management
Keywords: دوزوروبیسین لیپوزوم PEGylated; chemotherapy complications; chemotherapy nail complications; hand-foot skin reaction; hand-foot syndrome; molecular targeted therapy complications; palmoplantar erythrodysesthesia; FU; fluorouracil; GVHD; graft-versus-host disease; HFS; hand-foot syndrome
Pegylated Liposomal Doxorubicin in Recurrent Ovarian Cancer: Is There a Role for Maintenance Therapy?
Keywords: دوزوروبیسین لیپوزوم PEGylated; Improved survival; Increased progression free survival; Pegylated liposomal doxorubicin; Prolonged chemotherapy regimen; Treatment to best response
Clinical risk factors of PEGylated liposomal doxorubicin induced palmar plantar erythrodysesthesia in recurrent ovarian cancer patients
Keywords: دوزوروبیسین لیپوزوم PEGylated; Doxil; PEGylated liposomal doxorubicin; PPE; Palmar plantar erythrodysesthesia; Ovarian cancer
Intraductal Therapy of Ductal Carcinoma In Situ: A Presurgery Study
Keywords: دوزوروبیسین لیپوزوم PEGylated; Doxil; Ductal carcinoma in situ; Local therapy; Mammary duct; Pegylated liposomal doxorubicin
Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a “standard chemotherapy regimen”: The CASA randomized trial
Keywords: دوزوروبیسین لیپوزوم PEGylated; Adjuvant treatment; Endocrine nonresponsive; Chemotherapy; Pegylated liposomal doxorubicin; Elderly; Breast cancer
A phase II clinical trial of pegylated liposomal doxorubicin and carboplatin plus bevacizumab in patients with platinum-sensitive recurrent ovarian, fallopian tube, or primary peritoneal cancer
Keywords: دوزوروبیسین لیپوزوم PEGylated; Pegylated liposomal doxorubicin; Carboplatin; Bevacizumab; Ovarian cancer; Fallopian tube cancer; Primary peritoneal cancer
Patient-reported outcomes in relapsed ovarian cancer: Results from a randomized Phase III study of trabectedin with pegylated liposomal doxorubicin (PLD) versus PLD Alone ★
Keywords: دوزوروبیسین لیپوزوم PEGylated; Trabectedin; Yondelis®; Pegylated liposomal doxorubicin; DOXIL®; Relapsed ovarian cancer; Patient-reported outcome
Trabectedin plus pegylated liposomal doxorubicin (PLD) versus PLD in recurrent ovarian cancer: Overall survival analysis
Keywords: دوزوروبیسین لیپوزوم PEGylated; Trabectedin; Pegylated liposomal doxorubicin; Recurrent ovarian cancer;
Phase 2 trial of temozolomide and pegylated liposomal doxorubicin in the treatment of patients with glioblastoma multiforme following concurrent radiotherapy and chemotherapy
Keywords: دوزوروبیسین لیپوزوم PEGylated; Glioblastoma; Pegylated liposomal doxorubicin; Temozolomide;
Neoadjuvant pegylated liposomal doxorubicin in combination with cisplatin and infusional fluoruracil (CCF) with and without endocrine therapy in locally advanced primary or recurrent breast cancer
Keywords: دوزوروبیسین لیپوزوم PEGylated; Pegylated liposomal doxorubicin; Primary therapy; Breast cancer; Inflammatory breast cancer;
Pegylated liposomal doxorubicin in combination with low-dose metronomic cyclophosphamide as preoperative treatment for patients with locally advanced breast cancer
Keywords: دوزوروبیسین لیپوزوم PEGylated; Breast cancer; Locally advanced; Chemotherapy; Pegylated liposomal doxorubicin; Metronomic cyclophosphamide; Elderly
Effects of bevacizumab and pegylated liposomal doxorubicin for the patients with recurrent or refractory ovarian cancers
Keywords: دوزوروبیسین لیپوزوم PEGylated; Ovarian cancer; Refractory; Recurrent; Bevacizumab; Pegylated liposomal doxorubicin
Circulating tumor cells predict progression free survival and overall survival in patients with relapsed/recurrent advanced ovarian cancer
Keywords: دوزوروبیسین لیپوزوم PEGylated; Relapsed ovarian cancer; Trabectedin; Yondelis®; Pegylated liposomal doxorubicin; DOXIL®
Decreased hypersensitivity reactions with carboplatin-pegylated liposomal doxorubicin compared to carboplatin-paclitaxel combination: Analysis from the GCIG CALYPSO relapsing ovarian cancer trial
Keywords: دوزوروبیسین لیپوزوم PEGylated; Allergy; Carboplatin; Hypersensitivity reaction(s); Ovarian cancer; Pegylated liposomal doxorubicin
Chemotherapy-related bilateral dermatitis associated with eccrine squamous syringometaplasia: Reappraisal of epidemiological, clinical, and pathological features
Keywords: دوزوروبیسین لیپوزوم PEGylated; cytostatic agent; drug reaction; eccrine squamous syringometaplasia; intertriginous rash; oncology; pegylated liposomal doxorubicin
A phase II study of combination chemotherapy in early relapsed epithelial ovarian cancer using gemcitabine and pegylated liposomal doxorubicin
Keywords: دوزوروبیسین لیپوزوم PEGylated; Ovarian cancer; Chemotherapy; Gemcitabine; Pegylated liposomal doxorubicin; Relapsed; Phase II; Salvage
Carboplatin/gemcitabine alternating with carboplatin/pegylated liposomal doxorubicin and carboplatin/cyclophosphamide in platinum-refractory/resistant paclitaxel — pretreated ovarian carcinoma
Keywords: دوزوروبیسین لیپوزوم PEGylated; Platinum-refractory/resistant ovarian cancer; Alternating chemotherapy; Carboplatin; Gemcitabine; Pegylated liposomal doxorubicin; Cyclophosphamide
Pegylated liposomal doxorubicin combined with carboplatin: A rational treatment choice for advanced ovarian cancer
Keywords: دوزوروبیسین لیپوزوم PEGylated; Pegylated liposomal doxorubicin; Carboplatin; Platinum; Chemotherapy; Anthracycline; Ovarian cancer; Recurrent; Advanced disease
Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosis
Keywords: دوزوروبیسین لیپوزوم PEGylated; Fibromatosis; Desmoid tumour; Pegylated liposomal doxorubicin; Caelyx; Chemotherapy
Efficacy of pegylated liposomal doxorubicin (PLD) plus carboplatin in ovarian cancer patients who recur within six to twelve months: A phase II study
Keywords: دوزوروبیسین لیپوزوم PEGylated; Recurrent ovarian cancer; Pegylated liposomal doxorubicin; CA125; Carboplatin
Prevention strategies in palmar–plantar erythrodysesthesia onset: The role of regional cooling
Keywords: دوزوروبیسین لیپوزوم PEGylated; Palmar–plantar erythrodysesthesia; Pegylated liposomal doxorubicin; Regional cooling; Skin toxicity
Combination chemotherapy with carboplatin, paclitaxel and pegylated liposomal doxorubicin for advanced or recurrent carcinosarcoma of the uterus: Clinical experience of a single institution
Keywords: دوزوروبیسین لیپوزوم PEGylated; Carboplatin; Paclitaxel; Pegylated liposomal doxorubicin; Chemotherapy; Uterine carcinosarcoma
Randomized trial of pegylated liposomal doxorubicin (PLD) plus carboplatin versus carboplatin in platinum-sensitive (PS) patients with recurrent epithelial ovarian or peritoneal carcinoma after failure of initial platinum-based chemotherapy (Southwest Onc
Keywords: دوزوروبیسین لیپوزوم PEGylated; Platinum-sensitive; Ovarian cancer; Pegylated liposomal doxorubicin; Carboplatin
A pilot study to investigate the feasibility and cardiac effects of pegylated liposomal doxorubicin (PL-DOX) as adjuvant therapy in medically fit elderly breast cancer patients
Keywords: دوزوروبیسین لیپوزوم PEGylated; Breast cancer; Pegylated liposomal doxorubicin; Cardiac effects; Doppler myocardial imaging; Elderly
Strain Rate Imaging Detects Early Cardiac Effects of Pegylated Liposomal Doxorubicin as Adjuvant Therapy in Elderly Patients with Breast Cancer
Keywords: دوزوروبیسین لیپوزوم PEGylated; Breast cancer; Pegylated liposomal doxorubicin; Strain rate imaging;
Update on classic Kaposi sarcoma therapy: New look at an old disease
Keywords: دوزوروبیسین لیپوزوم PEGylated; Classic Kaposi sarcoma; Systemic therapy; Pegylated liposomal doxorubicin
Pegylated liposomal doxorubicin-associated hand–foot syndrome: Recommendations of an international panel of experts
Keywords: دوزوروبیسین لیپوزوم PEGylated; Hand–foot syndrome; Palmar–plantar erythrodysesthesia; Pegylated liposomal doxorubicin; Recommendations
Metastatic breast cancer: The role of pegylated liposomal doxorubicin after conventional anthracyclines
Keywords: دوزوروبیسین لیپوزوم PEGylated; Breast neoplasms; Anthracyclines; Pegylated liposomal doxorubicin
A joined analysis of two European Organization for the Research and Treatment of Cancer (EORTC) studies to evaluate the role of pegylated liposomal doxorubicin (Caelyx™) in the treatment of elderly patients with metastatic breast cancer
Keywords: دوزوروبیسین لیپوزوم PEGylated; Elderly; Pegylated liposomal doxorubicin; Breast cancer
A multicenter phase II study of pegylated liposomal doxorubicin and oxaliplatin in recurrent ovarian cancer
Keywords: دوزوروبیسین لیپوزوم PEGylated; Recurrent ovarian cancer; Salvage chemotherapy; Pegylated liposomal doxorubicin; Oxaliplatin
Pegylated liposomal doxorubicin treatment in recurrent gynecologic cancer patients with renal dysfunction
Keywords: دوزوروبیسین لیپوزوم PEGylated; Pegylated liposomal doxorubicin; Chronic kidney disease; Renal dysfunction; Renal failure; Ovarian cancer; Endometrial cancer
Combination therapy with pegylated liposomal doxorubicin and carboplatin in gynecologic malignancies: A prospective phase II study of the Arbeitsgemeinschaft Gynäekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and Kommission Uterus (AGO-K-U
Keywords: دوزوروبیسین لیپوزوم PEGylated; Platinum-sensitive ovarian cancer; Endometrial cancer; Uterine sarcoma; Pegylated liposomal doxorubicin; Carboplatin